Βy Prof. Daniele Regge [Chief of the Radiology Unit, Candiolo Cancer Institute, Torino-Italy] and Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] The clinical validation study was designed to assess the diagnostic performance of artificial intelligence (AI)...
Newsletter #8
ProCAncer-I: From Research to Market Impact
Βy Paris Ziogkas, the Co-Founder | CEO at Advantis Medical Imaging As the ProCAncer-I project reaches its conclusion, we celebrate a collective achievement that stands as a beacon of what European collaboration can deliver at the forefront of medical AI....
MRI quality assessment for Artificial Intelligence applications: Insights from the ProCancer I project
Βy Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] Acquisition of high-quality magnetic resonance imaging (MRI) examinations is essential for the accurate detection and characterization of prostate cancer, as poor image quality can obscure lesions and...
Researchers are using artificial intelligence to improve how prostate cancer is detected and diagnosed through MRI scans
Βy Nickolas Papanikolaou [Principal Investigator in Oncologic Imaging at the Fundação Champalimaud] Researchers are using artificial intelligence to improve how prostate cancer is detected and diagnosed through MRI scans. In one part of the project, the goal was to...
Newsletter #8 Contents
Highlights

ProCAncer-I project vision and results
Jul 2, 2025
The ProCAncer-I project aims to revolutionize prostate cancer diagnosis and treatment through the power of artificial intelligence and advanced imaging. By creating a large, federated database of prostate MRI scans and clinical data, the project enables the...

AI Improves prostate cancer (PCa) detection: Clinical Validation of AI models
Jun 24, 2025
ProCAncer-I results | Prof. Daniele Regge on clinical validation In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only...

Εstablishing robust AI Models for prostate cancer (PCa) care through data-driven decision support
Jun 19, 2025
ProCAncer-I results | Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I project has aimed to establish a robust, ethically compliant AI platform—ProstateNet—to revolutionize prostate cancer (PCa) care through...

Podcast Spotlight: How ProCAncer-I is paving the way for data-driven, patient-centric prostate cancer care with AI tools
Jun 5, 2025
In the following AI-generated audio file, ProCAncer-I achievements are described in a simple way. Since its inception, the ProCAncer-I project has been on a mission to transform prostate cancer (PCa) care through advanced AI and ethically compliant data platforms. At...